FDA approves device for preventing recurrent strokes in some patients

On Oct. 28, the Food and Drug Administration (FDA) approved the Amplatzer PFO Occluder device, which reduces the risk of a stroke in patients who previously had a stroke believed to be caused by a blood clot passing through a patent foramen ovale and then travelling to the brain. Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here